Platelet activating factor modulates microvascular permeability through nitric oxide synthesis
- PMID: 8538502
- DOI: 10.1006/mvre.1995.1055
Platelet activating factor modulates microvascular permeability through nitric oxide synthesis
Abstract
Biochemical signaling determines the specific action of vasomediators in the control of microvascular permeability and tone. We tested the hypothesis that nitric oxide (NO) synthesis is involved in the biochemical signaling pathway of platelet activating factor (PAF). The cheek pouch of anesthetized male Syrian hamsters was used as a microvascular model. Vessel diameter [expressed as the ratio of the experimental to the control (e/c) diameter, with control diameter normalized to 1] and extravasation of FITC-dextran 150 by integrated optical intensity (IOI) were determined using intravital fluorescent microscopy and computer-assisted digital image analysis. N-Nitro-L-arginine methyl ester (L-NAME) at 10(-5) and 10(-6) M and N-nitro-L-mono-methyl arginine (L-NMMA) at 10(-4) and 10(-5) M were used as inhibitors of NO synthase (NOS). Acetylcholine (ACh) and bradykinin were used as indirect indices of NOS activation. L-NAME and L-NMMA attenuated both ACh and bradykinin vasodilatory effects as well as the bradykinin-induced increase in vascular permeability. Topical PAF (10(-7) M) caused vasoconstriction (mean +/- SEM e/c ratio = 0.3 +/- 0.1) and increased IOI from a normalized baseline of 0 to 67.4 +/- 12.8. Topical administration of L-NAME produced differential effects on the series-arranged arterioles but had no effect on postcapillary venular permeability. L-NMMA did not influence the basal arteriolar diameter, but at 10(-5) M it caused a small increase in permeability (IOI = 14.3 +/- 4.2). In the presence of NOS inhibitors, PAF caused a reduced arteriolar constriction (e/c ratio = 0.6 +/- 0.1) relative to PAF alone. Both NOS inhibitors reduced the PAF-stimulated increase in vasopermeability. At 10(-5) M L-NMMA, the PAF-stimulated IOI mean value was 26.1 +/- 5.2, while at 10(-4) M L-NMMA the PAF-stimulated IOI was 15.2 +/- 2.6 compared to 10(-7) M PAF (67.4 +/- 12.8). These results support our hypothesis that NO synthesis is a step in the biochemical signaling pathway of the postcapillary cellular responses to PAF.
Similar articles
-
Platelet-activating factor modulates microvascular dynamics through phospholipase C in the hamster cheek pouch.Microvasc Res. 2000 Jan;59(1):7-13. doi: 10.1006/mvre.1999.2195. Microvasc Res. 2000. PMID: 10625566
-
Inhibition of nitric oxide synthase attenuates primed microvascular permeability in the in vivo microcirculation.J Vasc Surg. 1995 Dec;22(6):661-9; discussion 669-70. doi: 10.1016/s0741-5214(95)70056-0. J Vasc Surg. 1995. PMID: 8523600
-
Capillary reperfusion after L-arginine, L-NMMA, and L-NNA treatment in cheek pouch microvasculature.Microvasc Res. 1995 Sep;50(2):162-74. doi: 10.1006/mvre.1995.1050. Microvasc Res. 1995. PMID: 8538497
-
The hamster cheek pouch as a model in microcirculation research.Eur Respir J Suppl. 1990 Dec;12:595s-600s; discussion 600s-601s. Eur Respir J Suppl. 1990. PMID: 2076153 Review.
-
Recent findings on the mode of action of laxatives: the role of platelet activating factor and nitric oxide.Trends Pharmacol Sci. 1998 Oct;19(10):403-5. doi: 10.1016/s0165-6147(98)01249-8. Trends Pharmacol Sci. 1998. PMID: 9803830 Review.
Cited by
-
Rapamycin inhibits VEGF-induced microvascular hyperpermeability in vivo.Microcirculation. 2010 Feb;17(2):128-36. doi: 10.1111/j.1549-8719.2009.00012.x. Microcirculation. 2010. PMID: 20163539 Free PMC article.
-
S-Nitrosation of β-catenin and p120 catenin: a novel regulatory mechanism in endothelial hyperpermeability.Circ Res. 2012 Aug 17;111(5):553-63. doi: 10.1161/CIRCRESAHA.112.274548. Epub 2012 Jul 9. Circ Res. 2012. PMID: 22777005 Free PMC article.
-
Mitogen-activated protein kinases regulate platelet-activating factor-induced hyperpermeability.Microcirculation. 2005 Dec;12(8):637-43. doi: 10.1080/10739680500301706. Microcirculation. 2005. PMID: 16284005 Free PMC article.
-
Macular oedema: the role of soluble mediators.Br J Ophthalmol. 2000 May;84(5):542-5. doi: 10.1136/bjo.84.5.542. Br J Ophthalmol. 2000. PMID: 10781524 Free PMC article. Review. No abstract available.
-
The NO cascade, eNOS location, and microvascular permeability.Cardiovasc Res. 2010 Jul 15;87(2):254-61. doi: 10.1093/cvr/cvq139. Epub 2010 May 11. Cardiovasc Res. 2010. PMID: 20462865 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources